Form 4 for OM Outset Medical, Inc.
Accepted 2023-02-02 00:00:00 ET · period of report 2023-02-01 · accession 0001484612-23-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-02 | 2023-02-01 | OM | Trigg Leslie | COB, CEO, Dir | S - Sale+OE | $28.06 | -30.0K | 414.0K | -7% | -$841.8K |
| D | 2023-02-02 | 2023-02-01 | OM | Trigg Leslie | COB, CEO, Dir | M - OptEx | $3.88 | +30.0K | 444.0K | +7% | +$116.4K |
| D | 2023-02-02 | 2023-02-01 | OM | Trigg Leslie | COB, CEO, Dir | M - OptEx | $0.00 | -30.0K | 40.5K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | S | D | 30,000 | $28.06 | 414,044 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $27.00 - $27.99 - 14,718 shares; $28.00 - $28.99 - 15,282 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-02-01 | M | A | 30,000 | $3.88 | 444,044 | D | — | — | |
| 3 | Derivative | Performance Options (right to buy) | 2023-02-01 | M | D | 30,000 | $0.00 | 40,508 | D | $3.88 · — to 2027-09-19 | 30,000 Common Stock | (F3) In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |